New You Stock Total Asset
| NWYUDelisted Stock | USD 0.0003 0.00 0.00% |
New You fundamentals help investors to digest information that contributes to New You's financial success or failures. It also enables traders to predict the movement of New OTC Stock. The fundamental analysis module provides a way to measure New You's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to New You otc stock.
New |
New You OTC Stock Total Asset Analysis
New You's Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Current New You Total Asset | 197.09 K |
Most of New You's fundamental indicators, such as Total Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, New You is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
CompetitionBased on the latest financial disclosure, New You has a Total Asset of 197.09 K. This is 100.0% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The total asset for all United States stocks is 100.0% higher than that of the company.
New Total Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses New You's direct or indirect competition against its Total Asset to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of New You could also be used in its relative valuation, which is a method of valuing New You by comparing valuation metrics of similar companies.New You is currently under evaluation in total asset category among its peers.
New Fundamentals
| Return On Asset | -2.64 | |||
| Operating Margin | (2.67) % | |||
| Current Valuation | 1.46 M | |||
| Shares Outstanding | 49.95 M | |||
| Shares Owned By Insiders | 52.02 % | |||
| Price To Sales | 0.01 X | |||
| Revenue | 2.01 M | |||
| Gross Profit | 1.72 M | |||
| EBITDA | (4.24 M) | |||
| Net Income | (5.05 M) | |||
| Cash And Equivalents | 14.58 K | |||
| Total Debt | 128.88 K | |||
| Current Ratio | 0.01 X | |||
| Book Value Per Share | (0.24) X | |||
| Cash Flow From Operations | (486.37 K) | |||
| Earnings Per Share | (0.34) X | |||
| Beta | -8.46 | |||
| Market Capitalization | 14.99 K | |||
| Total Asset | 197.09 K | |||
| Z Score | -59.31 | |||
| Net Asset | 197.09 K |
About New You Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze New You's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of New You using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of New You based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Consideration for investing in New OTC Stock
If you are still planning to invest in New You check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the New You's history and understand the potential risks before investing.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |